OBJECTIVE: To clone the full length of renal cell carcinoma (RCC) related novel gene GYLZ-RCC18 and study its function. METHODS: SMART RACE technology was used to clone the full length of GYLZ-RCC18. RT-PCR was used t...OBJECTIVE: To clone the full length of renal cell carcinoma (RCC) related novel gene GYLZ-RCC18 and study its function. METHODS: SMART RACE technology was used to clone the full length of GYLZ-RCC18. RT-PCR was used to detect its expression in renal cell carcinoma tissue at different stages and grades. We transfected the antisense oligonucleotide of GYLZ-RCC18 to renal cell carcinoma cell line, GRC-1, and analyzed proliferation activity, growth rate, apoptosis, and mortality changes. RESULTS: The full length of GYLZ-RCC18 (GenBank accession number: BE825133) cDNA was about 3.5 kb. GYLZ-RCC18 had a higher expression in higher grades and stages of renal cell carcinoma than in lower ones. The expression of GYLZ-RCC18 in renal cell carcinoma was much higher than in normal kidney. After the transfection of GYLZ-RCC18 antisense oligonucleotide, the mortality of GRC-1 increased significantly, while proliferative activity and growth rate were substantially inhibited at the same time. The antisense oligonucleotide induced apoptosis of GRC-1 through the entire observation time. CONCLUSION: GYLZ-RCC18 is an important novel gene related to renal cell carcinoma. Overexpression of this gene results in higher growth and proliferative activity and has an antiapoptosis effect on renal cell carcinoma cells. Transfection of the antisense oligonucleotide may inhibit the generation and development of renal cell carcinoma.展开更多
After the renal cell carcinoma related novel gene fragment GYLZ-RCC18 was cloned by using suppression subtractive hybridization (SSH), we used the SMART RACE technology to clone the full length of GYLZ-RCC18 and perfo...After the renal cell carcinoma related novel gene fragment GYLZ-RCC18 was cloned by using suppression subtractive hybridization (SSH), we used the SMART RACE technology to clone the full length of GYLZ-RCC18 and performed chromosome location by the FISH method. RT-PCR was used to detect the expression of the first reading frame of GYLZ-RCC18 in different stages and grades of renal cell carcinoma tissue and other tissues. Also we trans-fected the antisense oligonucleotide of GYLZ-RCC18 to renal cell carcinoma cell line GRC-1, and analyzed the proliferation activity, growth speed, apoptosis and mortality changes in GRC-1. The results show that the full length of GYLZ-RCC18 (GenBank accession No.: BE825133) cDNA is about 3.5 kb long which is located at No. 14 chromosome. GYLZ-RCC18 has a higher expression in higher grades and stages of renal cell carcinoma than in the lower ones. The expression of GYLZ-RCC18 in renal cell carcinoma was much higher than that in normal kidney and other tissues. After展开更多
目的研究成纤维细胞生长因子18(FGF18)是否能诱导体外分离培养的人牙龈成纤维细胞(HGFs)向成骨样细胞分化,并探究其成骨机制。方法组织块法分离培养HGFs并鉴定。取第3代HGFs,分为实验组和对照组。实验组加入FGF18和L-DMEM、对照组加入L-...目的研究成纤维细胞生长因子18(FGF18)是否能诱导体外分离培养的人牙龈成纤维细胞(HGFs)向成骨样细胞分化,并探究其成骨机制。方法组织块法分离培养HGFs并鉴定。取第3代HGFs,分为实验组和对照组。实验组加入FGF18和L-DMEM、对照组加入L-DMEM。噻唑蓝(MTT)法检测不同浓度FGF18(0、0.01、0.02、0.04、0.06 mg/L)对HGFs增殖影响;碱性磷酸酶(ALP)和茜素红染色检测成骨能力和矿化能力;RT-PCR、免疫细胞化学染色及Western blot检测成骨相关基因、蛋白和BMP信号通路中BMP2基因和蛋白表达情况。结果与对照组比较,实验组培养3、5、7、9、11 d均可促进HGFs增殖(P<0.05);培养14、21 d ALP活性、矿物盐沉积均增高(P<0.05),ALP、OPN、OCN及BMP信号通路中BMP2 mRNA表达均明显增高(P<0.01)。培养21 d OPN、OCN及BMP2蛋白表达较培养14 d明显增高(P<0.01)。结论FGF18能促进HGFs增殖,诱导HGFs向功能性成骨样细胞分化,其成骨机制与上调BMP2有关。展开更多
基金ThisprojectwassupportedbyagrantfromtheNationalNaturalScienceFoundationofChina (No 3 9870 841)
文摘OBJECTIVE: To clone the full length of renal cell carcinoma (RCC) related novel gene GYLZ-RCC18 and study its function. METHODS: SMART RACE technology was used to clone the full length of GYLZ-RCC18. RT-PCR was used to detect its expression in renal cell carcinoma tissue at different stages and grades. We transfected the antisense oligonucleotide of GYLZ-RCC18 to renal cell carcinoma cell line, GRC-1, and analyzed proliferation activity, growth rate, apoptosis, and mortality changes. RESULTS: The full length of GYLZ-RCC18 (GenBank accession number: BE825133) cDNA was about 3.5 kb. GYLZ-RCC18 had a higher expression in higher grades and stages of renal cell carcinoma than in lower ones. The expression of GYLZ-RCC18 in renal cell carcinoma was much higher than in normal kidney. After the transfection of GYLZ-RCC18 antisense oligonucleotide, the mortality of GRC-1 increased significantly, while proliferative activity and growth rate were substantially inhibited at the same time. The antisense oligonucleotide induced apoptosis of GRC-1 through the entire observation time. CONCLUSION: GYLZ-RCC18 is an important novel gene related to renal cell carcinoma. Overexpression of this gene results in higher growth and proliferative activity and has an antiapoptosis effect on renal cell carcinoma cells. Transfection of the antisense oligonucleotide may inhibit the generation and development of renal cell carcinoma.
基金This work was supported by the National Natural Science Foundation of China (Grant No. 39870841).
文摘After the renal cell carcinoma related novel gene fragment GYLZ-RCC18 was cloned by using suppression subtractive hybridization (SSH), we used the SMART RACE technology to clone the full length of GYLZ-RCC18 and performed chromosome location by the FISH method. RT-PCR was used to detect the expression of the first reading frame of GYLZ-RCC18 in different stages and grades of renal cell carcinoma tissue and other tissues. Also we trans-fected the antisense oligonucleotide of GYLZ-RCC18 to renal cell carcinoma cell line GRC-1, and analyzed the proliferation activity, growth speed, apoptosis and mortality changes in GRC-1. The results show that the full length of GYLZ-RCC18 (GenBank accession No.: BE825133) cDNA is about 3.5 kb long which is located at No. 14 chromosome. GYLZ-RCC18 has a higher expression in higher grades and stages of renal cell carcinoma than in the lower ones. The expression of GYLZ-RCC18 in renal cell carcinoma was much higher than that in normal kidney and other tissues. After
文摘目的研究成纤维细胞生长因子18(FGF18)是否能诱导体外分离培养的人牙龈成纤维细胞(HGFs)向成骨样细胞分化,并探究其成骨机制。方法组织块法分离培养HGFs并鉴定。取第3代HGFs,分为实验组和对照组。实验组加入FGF18和L-DMEM、对照组加入L-DMEM。噻唑蓝(MTT)法检测不同浓度FGF18(0、0.01、0.02、0.04、0.06 mg/L)对HGFs增殖影响;碱性磷酸酶(ALP)和茜素红染色检测成骨能力和矿化能力;RT-PCR、免疫细胞化学染色及Western blot检测成骨相关基因、蛋白和BMP信号通路中BMP2基因和蛋白表达情况。结果与对照组比较,实验组培养3、5、7、9、11 d均可促进HGFs增殖(P<0.05);培养14、21 d ALP活性、矿物盐沉积均增高(P<0.05),ALP、OPN、OCN及BMP信号通路中BMP2 mRNA表达均明显增高(P<0.01)。培养21 d OPN、OCN及BMP2蛋白表达较培养14 d明显增高(P<0.01)。结论FGF18能促进HGFs增殖,诱导HGFs向功能性成骨样细胞分化,其成骨机制与上调BMP2有关。
